Antirheumatic Agent [EPC]

Antirheumatic Agent [EPC] was reported 105799 times

Drugs of the Antirheumatic Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 6253 0.8719
1 RHEUMATOID FACTOR NEGATIVE 151 0.8629
2 RED BLOOD CELL SEDIMENTATION RATE 219 0.7849
3 RHEUMATOID FACTOR POSITIVE 4501 0.7785
4 PEMPHIGUS 9528 0.7613
5 RHEUMATIC FEVER 3332 0.7468
6 SWOLLEN JOINT COUNT INCREASED 2379 0.7453
7 DUODENAL ULCER PERFORATION 5291 0.7108
8 C-REACTIVE PROTEIN 637 0.6872
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 1375 0.6865
10 LUPUS VULGARIS 846 0.6714
11 SWOLLEN JOINT COUNT 164 0.6560
12 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 438 0.6557
13 HAND DEFORMITY 8556 0.6517
14 FACET JOINT SYNDROME 2118 0.6499
15 GRIP STRENGTH 146 0.6376
16 HEPATIC ENZYME 92 0.6174
17 C-REACTIVE PROTEIN ABNORMAL 3940 0.6136
18 GRANULOMA SKIN 496 0.6041
19 MUSCULOSKELETAL DEFORMITY 137 0.5855
20 SYNOVITIS 10532 0.5835
21 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1340 0.5811
22 X-RAY ABNORMAL 964 0.5385
23 HYPOCHOLESTEROLAEMIA 190 0.5382
24 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1097 0.5289
25 MUSCLE INJURY 4351 0.5246
26 HELICOBACTER INFECTION 5318 0.5169
27 DISLOCATION OF VERTEBRA 1176 0.5151
28 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3161 0.4862
29 FOLLICULITIS 5075 0.4835
30 BONE EROSION 1627 0.4596
31 RETINITIS 732 0.4234
32 RHEUMATOID NODULE 1124 0.4077
33 JOINT LAXITY 123 0.4073
34 CONTRAINDICATED PRODUCT ADMINISTERED 12085 0.3987
35 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 223 0.3975
36 GLOSSODYNIA 8887 0.3965
37 PERIPHERAL VENOUS DISEASE 1608 0.3933
38 BLOOD PARATHYROID HORMONE DECREASED 576 0.3884
39 PERICARDITIS 6489 0.3858
40 BLOOD IRON ABNORMAL 357 0.3654
41 DRUG TOLERANCE DECREASED 1025 0.3646
42 SERONEGATIVE ARTHRITIS 382 0.3333
43 ANKLE ARTHROPLASTY 120 0.3306
44 RHEUMATOID LUNG 307 0.3215
45 LOOSE BODY IN JOINT 81 0.3045
46 CENTRAL NERVOUS SYSTEM LUPUS 67 0.3004
47 INTESTINAL SEPSIS 76 0.2901
48 SYSTEMIC LUPUS ERYTHEMATOSUS 10141 0.2854
49 BREAST CANCER STAGE III 1801 0.2778
50 JOINT DESTRUCTION 428 0.2751
51 WOUND 7417 0.2651
52 GRIP STRENGTH DECREASED 2253 0.2557
53 ENTHESOPATHY 400 0.2556
54 PANNICULITIS 615 0.2539
55 ANTICIPATORY ANXIETY 69 0.2537
56 TENOSYNOVITIS 698 0.2528
57 PORPHYRIA ACUTE 353 0.2460
58 WRIST DEFORMITY 146 0.2374
59 PRESBYACUSIS 73 0.2370
60 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2593 0.2341
61 JOINT RANGE OF MOTION DECREASED 3121 0.2325
62 ANKLE DEFORMITY 73 0.2274
63 DEAFNESS TRANSITORY 194 0.2272
64 IRRITABLE BOWEL SYNDROME 4874 0.2271
65 LIP DRY 2063 0.2269
66 RHEUMATOID ARTHRITIS 25580 0.2251
67 FINGER DEFORMITY 1090 0.2248
68 ONYCHOMADESIS 937 0.2230
69 NECK DEFORMITY 95 0.2140
70 BURSITIS 2573 0.2119
71 OVERLAP SYNDROME 144 0.2057
72 ARTHROPATHY 11241 0.2020
73 SYNOVIAL DISORDER 91 0.2000
74 ONYCHOMYCOSIS 874 0.1990
75 HYPERCHOLESTEROLAEMIA 1857 0.1921
76 WOUND INFECTION 2046 0.1866
77 THERAPEUTIC PRODUCT EFFECT DECREASED 8249 0.1840
78 LIVE BIRTH 1537 0.1835
79 FIBROMYALGIA 4382 0.1801
80 SOFT TISSUE SWELLING 102 0.1796
81 BLEPHAROSPASM 1103 0.1750
82 ARTHRODESIS 175 0.1719
83 DACTYLITIS 166 0.1690
84 DRUG INTOLERANCE 16099 0.1665
85 IMPAIRED HEALING 5462 0.1662
86 JOINT ANKYLOSIS 92 0.1620
87 PSORIATIC ARTHROPATHY 6311 0.1553
88 LIMB DEFORMITY 244 0.1535
89 NAIL DISORDER 1305 0.1490
90 BONE CYST 138 0.1471
91 C-REACTIVE PROTEIN DECREASED 96 0.1470
92 FOOT DEFORMITY 1614 0.1455
93 AUTOIMMUNE DISORDER 1398 0.1433
94 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 114 0.1429
95 LIVER INJURY 3498 0.1424
96 BLOOD PRESSURE SYSTOLIC ABNORMAL 346 0.1399
97 HYPERMOBILITY SYNDROME 69 0.1386
98 JOINT SWELLING 16140 0.1336
99 MEAN PLATELET VOLUME DECREASED 112 0.1335
100 TENOSYNOVITIS STENOSANS 74 0.1329
101 VASCULAR ACCESS COMPLICATION 106 0.1309
102 INFUSION SITE REACTION 390 0.1304
103 LOWER RESPIRATORY TRACT INFECTION 5838 0.1282
104 BLOOD PRESSURE DIASTOLIC ABNORMAL 324 0.1273
105 C-REACTIVE PROTEIN INCREASED 4625 0.1270
106 INTERVERTEBRAL DISC SPACE NARROWING 102 0.1266
107 SCIATICA 2004 0.1256
108 HEPATIC ENZYME INCREASED 8542 0.1252
109 PULMONARY FIBROSIS 2400 0.1250
110 TREATMENT FAILURE 10029 0.1209
111 INFUSION RELATED REACTION 8000 0.1206
112 EXOSTOSIS 1101 0.1204
113 DEATH NEONATAL 165 0.1185
114 ALANINE AMINOTRANSFERASE ABNORMAL 250 0.1184
115 TYPE 2 DIABETES MELLITUS 3979 0.1181
116 ALLERGY TO CHEMICALS 147 0.1180
117 JOINT ARTHROPLASTY 209 0.1166
118 SWELLING 10703 0.1142
119 PLEURAL THICKENING 78 0.1140
120 BONE SWELLING 109 0.1126
121 OBESITY 1794 0.1125
122 PRODUCT LABEL CONFUSION 655 0.1123
123 HIP ARTHROPLASTY 1711 0.1116
124 OSTEOARTHRITIS 4569 0.1077
125 BACK INJURY 1169 0.1074
126 SKIN NECROSIS 557 0.1073
127 MATERNAL EXPOSURE TIMING UNSPECIFIED 400 0.1064
128 PUSTULAR PSORIASIS 360 0.1047
129 POLYARTHRITIS 547 0.1037
130 SOFT TISSUE DISORDER 113 0.1019
131 PLEURAL FIBROSIS 103 0.1011
132 BLOODY DISCHARGE 115 0.1006
133 KNEE ARTHROPLASTY 2115 0.1004
134 PRURITUS ALLERGIC 117 0.1003
135 TUBERCULIN TEST POSITIVE 254 0.1002
136 DISCOMFORT 6065 0.0993
137 BLISTER 5484 0.0976
138 APPARENT DEATH 348 0.0965
139 BLOOD CHOLESTEROL INCREASED 4393 0.0941
140 MEAN CELL VOLUME DECREASED 145 0.0940
141 STOMATITIS 5581 0.0919
142 SYNOVIAL CYST 424 0.0917
143 MUSCULOSKELETAL STIFFNESS 8002 0.0912
144 LUPUS-LIKE SYNDROME 827 0.0911
145 VASCULITIC RASH 70 0.0907
146 RHEUMATOID FACTOR INCREASED 100 0.0895
147 DRUG TOLERANCE 451 0.0891
148 SHOULDER ARTHROPLASTY 236 0.0875
149 GAIT INABILITY 2928 0.0875
150 COELIAC DISEASE 856 0.0872
151 LIVER FUNCTION TEST INCREASED 1865 0.0868
152 BLOOD MAGNESIUM INCREASED 78 0.0865
153 LOWER LIMB FRACTURE 1661 0.0864
154 JOINT EFFUSION 590 0.0855
155 RETINAL TOXICITY 88 0.0854
156 BUTTERFLY RASH 85 0.0838
157 INFLAMMATION 4295 0.0831
158 MEAN CELL HAEMOGLOBIN DECREASED 151 0.0824
159 NIGHT SWEATS 2649 0.0821
160 PRESCRIBED OVERDOSE 1554 0.0802
161 WALKING AID USER 528 0.0800
162 MOBILITY DECREASED 5750 0.0799
163 INTERNATIONAL NORMALISED RATIO FLUCTUATION 163 0.0787
164 MYCOTIC ALLERGY 66 0.0772
165 OSTEOSCLEROSIS 121 0.0768
166 SURGICAL FAILURE 88 0.0761
167 MATERNAL EXPOSURE DURING PREGNANCY 6604 0.0740
168 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3557 0.0740
169 ILL-DEFINED DISORDER 4456 0.0733
170 BREAST CANCER STAGE II 608 0.0730
171 ABDOMINAL DISCOMFORT 12213 0.0727
172 JOINT DISLOCATION 768 0.0726
173 INVESTIGATION ABNORMAL 101 0.0702
174 CONGENITAL ANOMALY 544 0.0702
175 JOINT NOISE 138 0.0702
176 FOOT OPERATION 347 0.0700
177 ULCER HAEMORRHAGE 461 0.0681
178 MUSCULOSKELETAL PAIN 3543 0.0676
179 JOINT STIFFNESS 1760 0.0670
180 BRONCHITIS CHRONIC 162 0.0663
181 FINE MOTOR SKILL DYSFUNCTION 192 0.0663
182 GASTROINTESTINAL DISORDER 5888 0.0657
183 DEFORMITY 599 0.0640
184 PRESCRIBED UNDERDOSE 1269 0.0635
185 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 149 0.0627
186 CHONDROPATHY 170 0.0627
187 ADVERSE REACTION 828 0.0624
188 PERIPHERAL SWELLING 9612 0.0623
189 EYE INJURY 189 0.0622
190 ALOPECIA 12130 0.0617
191 NODULE 805 0.0616
192 HEPATIC FIBROSIS 211 0.0614
193 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 143 0.0610
194 ARTHRITIS BACTERIAL 250 0.0609
195 SPONDYLITIS 221 0.0607
196 EAR PAIN 1180 0.0606
197 JUVENILE IDIOPATHIC ARTHRITIS 148 0.0605
198 CREPITATIONS 180 0.0604
199 PULMONARY TOXICITY 422 0.0596
200 RHEUMATIC DISORDER 115 0.0594
201 PNEUMONIA VIRAL 189 0.0592
202 LABILE BLOOD PRESSURE 70 0.0589
203 SPINAL COLUMN INJURY 129 0.0578
204 OSTEOPOROTIC FRACTURE 110 0.0574
205 SPINAL STENOSIS 236 0.0571
206 SINUSITIS 5850 0.0570
207 RASH VESICULAR 274 0.0566
208 SENSITIVITY TO WEATHER CHANGE 297 0.0564
209 DEMYELINATION 231 0.0563
210 DRUG ERUPTION 997 0.0562
211 HEPATIC CIRRHOSIS 1055 0.0561
212 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3960 0.0556
213 LUNG DISORDER 2722 0.0555
214 MUSCLE SPASTICITY 677 0.0550
215 ORAL MUCOSAL EXFOLIATION 81 0.0535
216 DISABILITY 1047 0.0529
217 HEPATITIS 1326 0.0518
218 HEPATIC ENZYME ABNORMAL 258 0.0517
219 HYPERSENSITIVITY 9541 0.0513
220 INFECTION 7396 0.0510
221 THYROID NEOPLASM 140 0.0507
222 WHEEZING 3009 0.0507
223 LIVER DISORDER 2241 0.0505
224 SLEEP DISORDER 3559 0.0504
225 PRERENAL FAILURE 71 0.0504
226 GENERAL PHYSICAL HEALTH DETERIORATION 5825 0.0503
227 SKIN ULCER 1290 0.0499
228 INTENTIONAL PRODUCT USE ISSUE 4341 0.0495
229 INJURY 3435 0.0488
230 INFLAMMATORY MARKER INCREASED 242 0.0488
231 HYPERCALCAEMIA 602 0.0487
232 TASTE DISORDER 980 0.0483
233 BASAL CELL CARCINOMA 753 0.0482
234 OSTEOPOROSIS 1960 0.0476
235 ARTHRITIS 3741 0.0475
236 NORMAL NEWBORN 258 0.0474
237 SPINAL FUSION SURGERY 191 0.0470
238 ARTHRITIS INFECTIVE 218 0.0470
239 DRUG-INDUCED LIVER INJURY 1471 0.0468
240 THERAPY NON-RESPONDER 2107 0.0468
241 MUSCULOSKELETAL DISORDER 881 0.0462
242 DERMATITIS PSORIASIFORM 94 0.0460
243 GRANULOMA 159 0.0459
244 ANTINUCLEAR ANTIBODY POSITIVE 148 0.0455
245 KNEE DEFORMITY 67 0.0451
246 SARCOIDOSIS 214 0.0450
247 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 771 0.0449
248 ULCER 709 0.0445
249 EXPOSURE DURING PREGNANCY 2759 0.0443
250 BLOOD PRESSURE SYSTOLIC INCREASED 851 0.0436
251 HEPATOTOXICITY 969 0.0435
252 PULMONARY MASS 639 0.0429
253 OEDEMA 2321 0.0428
254 NEOPLASM SKIN 66 0.0425
255 LATENT TUBERCULOSIS 89 0.0425
256 ARTHRALGIA 17647 0.0424
257 BODY TEMPERATURE INCREASED 864 0.0423
258 JOINT LOCK 120 0.0422
259 ROAD TRAFFIC ACCIDENT 1755 0.0419
260 EAR INFECTION 1111 0.0417
261 CONTUSION 3987 0.0414
262 SKIN PAPILLOMA 166 0.0414
263 LUPUS NEPHRITIS 76 0.0406
264 RESPIRATORY DISORDER 1215 0.0406
265 ANKYLOSING SPONDYLITIS 535 0.0406
266 COLITIS MICROSCOPIC 191 0.0403
267 OSTEOLYSIS 82 0.0401
268 PHYSICAL DISABILITY 176 0.0398
269 PREGNANCY 797 0.0398
270 SACROILIITIS 75 0.0397
271 IMMOBILE 171 0.0391
272 EPILEPSY 1197 0.0391
273 BONE DENSITY ABNORMAL 145 0.0388
274 VIRAL UPPER RESPIRATORY TRACT INFECTION 184 0.0387
275 CARTILAGE INJURY 95 0.0385
276 WHEELCHAIR USER 170 0.0382
277 WHITE BLOOD CELL COUNT ABNORMAL 244 0.0382
278 PHARYNGITIS 473 0.0381
279 NECK MASS 106 0.0374
280 NASOPHARYNGITIS 6896 0.0374
281 MONOCYTE COUNT INCREASED 134 0.0369
282 IMMUNODEFICIENCY 546 0.0366
283 TENDERNESS 381 0.0365
284 FUNCTIONAL GASTROINTESTINAL DISORDER 126 0.0364
285 INTERVERTEBRAL DISC DEGENERATION 335 0.0362
286 DIVERTICULITIS 1002 0.0361
287 BRONCHIECTASIS 243 0.0360
288 CUTANEOUS LUPUS ERYTHEMATOSUS 70 0.0360
289 NECK PAIN 2006 0.0359
290 CONDITION AGGRAVATED 10830 0.0356
291 MYOSITIS 319 0.0355
292 DRY MOUTH 2882 0.0355
293 LYME DISEASE 118 0.0354
294 TONGUE DISORDER 256 0.0353
295 BLOOD PRESSURE DIASTOLIC INCREASED 163 0.0353
296 MOUTH ULCERATION 731 0.0347
297 PRODUCT USE ISSUE 6514 0.0346
298 BLOOD PRESSURE FLUCTUATION 819 0.0341
299 DELIRIUM 1178 0.0339
300 PAIN 20686 0.0336
301 LOSS OF EMPLOYMENT 100 0.0331
302 THERAPEUTIC RESPONSE DECREASED 1965 0.0324
303 JOINT INJURY 687 0.0321
304 EPIGASTRIC DISCOMFORT 125 0.0320
305 FOOD INTOLERANCE 117 0.0319
306 DEAFNESS NEUROSENSORY 105 0.0319
307 LOCALISED INFECTION 772 0.0319
308 RASH 13907 0.0319
309 BLOOD PRESSURE DIASTOLIC DECREASED 235 0.0318
310 RED CELL DISTRIBUTION WIDTH INCREASED 132 0.0317
311 HYPERTENSION 6686 0.0315
312 POSTOPERATIVE WOUND INFECTION 212 0.0314
313 IMPAIRED WORK ABILITY 666 0.0311
314 GENERAL SYMPTOM 231 0.0308
315 GASTROINTESTINAL PAIN 339 0.0308
316 BODY TEMPERATURE DECREASED 303 0.0307
317 BREATH SOUNDS ABNORMAL 151 0.0306
318 HYPOAESTHESIA 4581 0.0306
319 CONFUSIONAL STATE 4919 0.0304
320 OSTEOMYELITIS 551 0.0304
321 TENDONITIS 464 0.0299
322 URTICARIA 4943 0.0295
323 HEPATIC STEATOSIS 543 0.0291
324 DYSPEPSIA 2849 0.0289
325 CARPAL TUNNEL SYNDROME 404 0.0288
326 GASTROINTESTINAL TOXICITY 138 0.0287
327 DRUG INEFFECTIVE 37634 0.0285
328 INTERVERTEBRAL DISC PROTRUSION 623 0.0285
329 CUTANEOUS VASCULITIS 104 0.0285
330 WEIGHT INCREASED 6376 0.0284
331 BACK DISORDER 462 0.0284
332 FEAR OF INJECTION 202 0.0283
333 TENDON DISORDER 184 0.0282
334 PEPTIC ULCER 93 0.0280
335 INTERSTITIAL LUNG DISEASE 1356 0.0280
336 ACNE CYSTIC 82 0.0272
337 ROTATOR CUFF SYNDROME 347 0.0270
338 TOOTH INFECTION 356 0.0270
339 LIMB OPERATION 128 0.0267
340 PAIN IN EXTREMITY 7831 0.0266
341 ENDODONTIC PROCEDURE 67 0.0264
342 BK VIRUS INFECTION 89 0.0264
343 SPINAL DISORDER 245 0.0258
344 DRUG EFFECT INCOMPLETE 939 0.0258
345 LIVER FUNCTION TEST ABNORMAL 745 0.0256
346 INJECTION SITE HYPERSENSITIVITY 80 0.0256
347 MIGRAINE 2430 0.0254
348 ALANINE AMINOTRANSFERASE INCREASED 1559 0.0254
349 SPINAL OSTEOARTHRITIS 223 0.0254
350 PULMONARY THROMBOSIS 276 0.0253
351 VASCULITIS 294 0.0252
352 TERMINAL STATE 167 0.0249
353 ADVERSE DRUG REACTION 2236 0.0249
354 ADVERSE EVENT 2283 0.0247
355 DERMATITIS ALLERGIC 310 0.0246
356 SUSPECTED OFF LABEL USE 111 0.0245
357 ADRENAL INSUFFICIENCY 296 0.0244
358 SCOLIOSIS 151 0.0244
359 BONE DISORDER 442 0.0242
360 TRIGGER FINGER 98 0.0240
361 ASPARTATE AMINOTRANSFERASE INCREASED 1270 0.0239
362 HERPES ZOSTER 1370 0.0238
363 DYSLIPIDAEMIA 121 0.0238
364 RASH PRURITIC 1288 0.0237
365 CUSHINGOID 76 0.0237
366 CYST 292 0.0235
367 UPPER RESPIRATORY TRACT INFECTION 1087 0.0235
368 GAIT DISTURBANCE 4499 0.0235
369 IRON DEFICIENCY 105 0.0233
370 ABDOMINAL PAIN UPPER 4796 0.0233
371 INJECTION SITE REACTION 1599 0.0232
372 SKIN REACTION 325 0.0230
373 BONE LESION 83 0.0230
374 LIMB DISCOMFORT 710 0.0229
375 FEMUR FRACTURE 710 0.0229
376 SPINAL COLUMN STENOSIS 108 0.0228
377 FOOT FRACTURE 432 0.0228
378 INTERVERTEBRAL DISC DISORDER 97 0.0227
379 POST PROCEDURAL INFECTION 184 0.0226
380 SECRETION DISCHARGE 283 0.0226
381 GASTROOESOPHAGEAL REFLUX DISEASE 1810 0.0225
382 CYTOMEGALOVIRUS VIRAEMIA 99 0.0222
383 PLANTAR FASCIITIS 74 0.0220
384 ABSCESS LIMB 94 0.0220
385 LUNG NEOPLASM 94 0.0220
386 MUSCULOSKELETAL DISCOMFORT 377 0.0219
387 HYPERKERATOSIS 120 0.0217
388 DRUG USE DISORDER 182 0.0216
389 GASTRIC DISORDER 739 0.0215
390 HYPERTRANSAMINASAEMIA 148 0.0213
391 LEUKOPENIA 1062 0.0212
392 MUSCULAR WEAKNESS 2407 0.0212
393 POOR VENOUS ACCESS 219 0.0211
394 AMNESIA 1373 0.0211
395 PLEURISY 125 0.0210
396 ENCEPHALITIS 145 0.0209
397 OSTEOPENIA 316 0.0208
398 NERVE COMPRESSION 191 0.0207
399 MENISCUS INJURY 127 0.0206
400 HAEMOGLOBIN INCREASED 94 0.0206
401 CHRONIC SINUSITIS 77 0.0205
402 FATIGUE 15965 0.0205
403 PROTEIN URINE PRESENT 102 0.0204
404 MULTIPLE ALLERGIES 160 0.0204
405 UVEITIS 276 0.0203
406 APHTHOUS ULCER 156 0.0201
407 PNEUMONIA 6440 0.0199
408 TOOTH DISORDER 439 0.0197
409 TOOTH ABSCESS 201 0.0197
410 ANAPHYLACTIC REACTION 1089 0.0197
411 SKIN LACERATION 213 0.0196
412 BRONCHITIS 1449 0.0196
413 PLATELET COUNT INCREASED 254 0.0195
414 THYROID DISORDER 300 0.0194
415 TOOTH FRACTURE 214 0.0194
416 PHOTOSENSITIVITY REACTION 320 0.0194
417 WEIGHT FLUCTUATION 202 0.0193
418 ESCHERICHIA URINARY TRACT INFECTION 82 0.0193
419 PURULENT DISCHARGE 82 0.0192
420 HAEMORRHAGIC DIATHESIS 68 0.0191
421 IMMUNOSUPPRESSION 165 0.0187
422 PULMONARY TUBERCULOSIS 79 0.0185
423 SKIN INFECTION 207 0.0184
424 IRON DEFICIENCY ANAEMIA 170 0.0184
425 ORAL DISORDER 135 0.0184
426 TRANSAMINASES INCREASED 408 0.0183
427 FURUNCLE 145 0.0183
428 DIVERTICULUM 130 0.0183
429 PNEUMOCYSTIS JIROVECII PNEUMONIA 183 0.0182
430 SKIN WARM 106 0.0182
431 BLOOD CHOLESTEROL ABNORMAL 84 0.0182
432 PYREXIA 6266 0.0181
433 RESPIRATORY TRACT CONGESTION 287 0.0180
434 ASTHMA 2041 0.0180
435 MEDICATION ERROR 1003 0.0180
436 BEDRIDDEN 237 0.0180
437 DYSSTASIA 524 0.0179
438 PSORIASIS 2341 0.0179
439 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 304 0.0179
440 GLAUCOMA 344 0.0178
441 CANDIDA INFECTION 301 0.0178
442 PARAESTHESIA 2801 0.0178
443 INSOMNIA 4736 0.0178
444 SPINAL PAIN 208 0.0177
445 RALES 101 0.0174
446 LYMPHOMA 268 0.0173
447 MEMORY IMPAIRMENT 2373 0.0173
448 ORAL DISCOMFORT 238 0.0171
449 INJECTION SITE INFLAMMATION 85 0.0170
450 EMPHYSEMA 171 0.0169
451 IMPAIRED GASTRIC EMPTYING 230 0.0169
452 DRUG EFFECT DECREASED 902 0.0167
453 HYPOKINESIA 243 0.0167
454 ABNORMAL LOSS OF WEIGHT 114 0.0167
455 STRESS FRACTURE 90 0.0167
456 PRURITUS 6372 0.0166
457 GASTRIC ULCER 315 0.0166
458 KIDNEY INFECTION 325 0.0165
459 FREQUENT BOWEL MOVEMENTS 447 0.0165
460 LUNG INFECTION 257 0.0165
461 CATARACT OPERATION 98 0.0165
462 LABORATORY TEST ABNORMAL 486 0.0165
463 INCORRECT DOSAGE ADMINISTERED 80 0.0163
464 ORAL HERPES 316 0.0162
465 MALAISE 7092 0.0162
466 OEDEMA PERIPHERAL 1971 0.0162
467 SKIN LESION 442 0.0161
468 UROSEPSIS 147 0.0159
469 CATARACT 946 0.0159
470 RHINITIS 128 0.0159
471 DRUG SPECIFIC ANTIBODY PRESENT 103 0.0158
472 GINGIVITIS 85 0.0157
473 LUMBAR VERTEBRAL FRACTURE 72 0.0157
474 CHEST PAIN 2896 0.0156
475 FEEDING DISORDER 317 0.0156
476 SQUAMOUS CELL CARCINOMA 147 0.0156
477 MASS 218 0.0156
478 ENDOCARDITIS 80 0.0156
479 ERYSIPELAS 78 0.0155
480 DECREASED APPETITE 3576 0.0154
481 DUODENAL ULCER 108 0.0153
482 VOMITING 7196 0.0153
483 ORAL PAIN 342 0.0153
484 EYE DISORDER 498 0.0151
485 DEAFNESS 396 0.0151
486 HEADACHE 9415 0.0150
487 ONYCHOCLASIS 103 0.0150
488 ORAL CANDIDIASIS 197 0.0149
489 SPINAL OPERATION 184 0.0149
490 WHITE BLOOD CELL COUNT INCREASED 573 0.0149
491 DIARRHOEA 9625 0.0149
492 COVID-19 PNEUMONIA 175 0.0148
493 PNEUMONITIS 403 0.0148
494 TENDON RUPTURE 182 0.0147
495 HERPES VIRUS INFECTION 84 0.0146
496 SKIN PLAQUE 123 0.0146
497 HEART RATE DECREASED 511 0.0145
498 BACK PAIN 3369 0.0145
499 PATHOLOGICAL FRACTURE 73 0.0144
500 STAPHYLOCOCCAL SEPSIS 71 0.0144
501 DECREASED IMMUNE RESPONSIVENESS 141 0.0144
502 PERIPHERAL VASCULAR DISORDER 74 0.0143
503 GROIN PAIN 126 0.0143
504 MUSCLE SPASMS 2625 0.0143
505 CELLULITIS 720 0.0143
506 OFF LABEL USE 12501 0.0143
507 WEIGHT DECREASED 3984 0.0143
508 MOVEMENT DISORDER 458 0.0142
509 MATERNAL EXPOSURE BEFORE PREGNANCY 97 0.0142
510 SKIN MASS 94 0.0141
511 DEPRESSION 3197 0.0140
512 HIP SURGERY 76 0.0140
513 GAMMA-GLUTAMYLTRANSFERASE INCREASED 311 0.0140
514 BLOOD IRON DECREASED 166 0.0140
515 STAPHYLOCOCCAL INFECTION 461 0.0140
516 POLYNEUROPATHY 167 0.0139
517 ANAL ABSCESS 75 0.0139
518 INJECTION SITE IRRITATION 177 0.0139
519 ACCIDENT 165 0.0138
520 BLOOD ALKALINE PHOSPHATASE INCREASED 343 0.0138
521 HYPOGAMMAGLOBULINAEMIA 90 0.0137
522 PHLEBITIS 70 0.0137
523 ASTHENIA 5135 0.0136
524 INJECTION SITE HAEMATOMA 198 0.0136
525 MULTIPLE FRACTURES 223 0.0136
526 RESPIRATORY TRACT INFECTION 353 0.0135
527 HAEMATOCRIT DECREASED 268 0.0135
528 IMMUNE SYSTEM DISORDER 178 0.0135
529 ANKLE FRACTURE 209 0.0135
530 RECTAL HAEMORRHAGE 580 0.0135
531 DIABETES MELLITUS 1029 0.0135
532 FRACTURE 255 0.0135
533 PRODUCT USE IN UNAPPROVED INDICATION 3322 0.0134
534 EYE INFECTION 151 0.0134
535 HERNIA 258 0.0133
536 NAUSEA 10545 0.0133
537 SPUTUM DISCOLOURED 126 0.0133
538 BLOOD TEST ABNORMAL 186 0.0132
539 RASH MACULO-PAPULAR 293 0.0132
540 SCAB 150 0.0131
541 VITAMIN D DECREASED 112 0.0131
542 LIMB INJURY 354 0.0130
543 CYSTITIS 414 0.0130
544 NEPHROLITHIASIS 596 0.0130
545 TYPE 1 DIABETES MELLITUS 78 0.0129
546 LIGAMENT SPRAIN 128 0.0129
547 OXYGEN SATURATION DECREASED 724 0.0129
548 DRY EYE 643 0.0129
549 MENINGITIS 86 0.0129
550 DYSPNOEA 7283 0.0129
551 SINUS CONGESTION 173 0.0128
552 INFLUENZA 1423 0.0127
553 PHARYNGEAL OEDEMA 196 0.0127
554 GASTROENTERITIS VIRAL 229 0.0127
555 RENAL CYST 100 0.0126
556 NERVE INJURY 140 0.0126
557 BLOOD PRESSURE INCREASED 1916 0.0125
558 RESPIRATORY RATE INCREASED 111 0.0125
559 HYPERTENSIVE CRISIS 139 0.0125
560 GASTROINTESTINAL INFECTION 112 0.0125
561 ABDOMINAL PAIN 2895 0.0124
562 PANCREATITIS 654 0.0124
563 SINUS HEADACHE 73 0.0123
564 PYELONEPHRITIS 106 0.0122
565 INJECTION SITE WARMTH 249 0.0121
566 SPINAL COMPRESSION FRACTURE 100 0.0121
567 STREPTOCOCCAL INFECTION 67 0.0120
568 FEELING HOT 735 0.0120
569 LOCAL SWELLING 209 0.0120
570 FUNGAL INFECTION 399 0.0120
571 ECCHYMOSIS 82 0.0119
572 DERMATITIS 250 0.0119
573 PRODUCTIVE COUGH 569 0.0119
574 SKIN DISORDER 397 0.0119
575 ABDOMINAL DISTENSION 1242 0.0119
576 LYMPHOEDEMA 82 0.0118
577 INJECTION SITE PRURITUS 789 0.0118
578 PELVIC FRACTURE 90 0.0115
579 HERPES SIMPLEX 75 0.0115
580 HEPATIC FUNCTION ABNORMAL 429 0.0115
581 MOUTH HAEMORRHAGE 84 0.0114
582 VISUAL IMPAIRMENT 1419 0.0114
583 BLOOD LACTATE DEHYDROGENASE INCREASED 181 0.0114
584 DENTAL CARIES 126 0.0114
585 VITAMIN D DEFICIENCY 111 0.0114
586 GASTROENTERITIS 165 0.0113
587 HYPOVOLAEMIA 66 0.0113
588 DRUG EXPOSURE DURING PREGNANCY 382 0.0112
589 CARDIAC MURMUR 97 0.0112
590 SCAR 191 0.0111
591 TOOTHACHE 199 0.0110
592 TOOTH EXTRACTION 136 0.0109
593 HYPOPHAGIA 278 0.0109
594 SEPTIC SHOCK 472 0.0108
595 RED BLOOD CELL COUNT DECREASED 309 0.0108
596 NEPHROPATHY 100 0.0107
597 COLITIS ULCERATIVE 478 0.0107
598 UNDERDOSE 777 0.0106
599 LUNG INFILTRATION 94 0.0106
600 PAIN IN JAW 301 0.0106
601 RHINORRHOEA 685 0.0106
602 PNEUMONIA BACTERIAL 97 0.0106
603 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 79 0.0105
604 LYMPHADENOPATHY 372 0.0105
605 MUSCULOSKELETAL CHEST PAIN 162 0.0105
606 BLOOD ALBUMIN DECREASED 83 0.0105
607 PANCYTOPENIA 580 0.0104
608 NEURALGIA 251 0.0103
609 MUSCLE STRAIN 89 0.0103
610 DEEP VEIN THROMBOSIS 667 0.0103
611 ATELECTASIS 99 0.0102
612 HAEMOGLOBIN DECREASED 1038 0.0101
613 PULMONARY CONGESTION 133 0.0101
614 COUGH 2816 0.0100
615 GALLBLADDER DISORDER 179 0.0100
616 ARTHROPOD BITE 74 0.0100
617 DIZZINESS 4968 0.0100
618 DRUG RESISTANCE 255 0.0099
619 INJECTION SITE DISCOLOURATION 124 0.0099
620 THERAPEUTIC RESPONSE SHORTENED 326 0.0098
621 EATING DISORDER 208 0.0098
622 PATHOGEN RESISTANCE 89 0.0098
623 NASAL CONGESTION 569 0.0097
624 URINARY TRACT INFECTION 1649 0.0097
625 FALL 3205 0.0096
626 SEPSIS 1067 0.0096
627 POST PROCEDURAL COMPLICATION 183 0.0095
628 MALIGNANT MELANOMA 127 0.0095
629 OROPHARYNGEAL PAIN 873 0.0094
630 HYPOTHYROIDISM 301 0.0094
631 BACTERIAL INFECTION 175 0.0094
632 ABORTION INDUCED 88 0.0093
633 CONJUNCTIVITIS 172 0.0093
634 INJECTION SITE ERYTHEMA 1149 0.0093
635 BLOOD CREATININE INCREASED 604 0.0092
636 HYSTERECTOMY 80 0.0092
637 FLUID RETENTION 469 0.0092
638 PLEURAL EFFUSION 558 0.0092
639 INCREASED TENDENCY TO BRUISE 84 0.0091
640 HIATUS HERNIA 118 0.0091
641 BONE DENSITY DECREASED 285 0.0091
642 HYDRONEPHROSIS 68 0.0091
643 BODY HEIGHT DECREASED 97 0.0091
644 SEASONAL ALLERGY 128 0.0090
645 NEOPLASM MALIGNANT 603 0.0090
646 BLOOD URINE PRESENT 171 0.0090
647 STENT PLACEMENT 72 0.0089
648 EYE HAEMORRHAGE 119 0.0089
649 FRUSTRATION TOLERANCE DECREASED 72 0.0089
650 VIRAL INFECTION 295 0.0089
651 PSEUDOMONAS INFECTION 76 0.0089
652 WHITE BLOOD CELL COUNT DECREASED 958 0.0088
653 MUCOSAL INFLAMMATION 231 0.0088
654 QUALITY OF LIFE DECREASED 118 0.0088
655 CYTOMEGALOVIRUS INFECTION 146 0.0088
656 MOTOR DYSFUNCTION 89 0.0087
657 PHARYNGITIS STREPTOCOCCAL 94 0.0087
658 INJECTION SITE INDURATION 112 0.0086
659 SPINAL FRACTURE 173 0.0086
660 PULMONARY EMBOLISM 818 0.0086
661 UPPER LIMB FRACTURE 171 0.0086
662 RENAL IMPAIRMENT 719 0.0085
663 GLOMERULAR FILTRATION RATE DECREASED 105 0.0085
664 ARTERIAL OCCLUSIVE DISEASE 67 0.0085
665 ESCHERICHIA INFECTION 70 0.0085
666 RIB FRACTURE 175 0.0085
667 CYTOPENIA 104 0.0085
668 ABSCESS 135 0.0085
669 HYPOCALCAEMIA 160 0.0084
670 HYPERLIPIDAEMIA 101 0.0084
671 ERYTHEMA 1734 0.0084
672 AFFECTIVE DISORDER 66 0.0084
673 GASTRITIS 220 0.0084
674 CHOLELITHIASIS 274 0.0083
675 WRIST FRACTURE 100 0.0083
676 MULTI-ORGAN FAILURE 144 0.0083
677 CLOSTRIDIUM DIFFICILE INFECTION 181 0.0083
678 INJECTION SITE SWELLING 635 0.0083
679 LOSS OF CONSCIOUSNESS 1058 0.0082
680 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 68 0.0082
681 SLEEP APNOEA SYNDROME 157 0.0082
682 GINGIVAL BLEEDING 112 0.0082
683 ANAPHYLACTIC SHOCK 211 0.0082
684 BLOOD PRESSURE ABNORMAL 162 0.0081
685 HEART RATE IRREGULAR 184 0.0081
686 MUSCLE ATROPHY 103 0.0081
687 PRURITUS GENERALISED 175 0.0081
688 THYROID CANCER 97 0.0081
689 THROMBOSIS 648 0.0080
690 NEUROPATHY PERIPHERAL 766 0.0080
691 HYPERAESTHESIA 66 0.0080
692 FOETAL EXPOSURE DURING PREGNANCY 653 0.0080
693 DIARRHOEA HAEMORRHAGIC 75 0.0080
694 INTESTINAL PERFORATION 90 0.0080
695 KNEE OPERATION 78 0.0079
696 SKIN SWELLING 68 0.0078
697 HEPATOCELLULAR INJURY 111 0.0078
698 OVARIAN CANCER 72 0.0078
699 INJECTION SITE RASH 239 0.0078
700 INJECTION SITE BRUISING 617 0.0077
701 RENAL FAILURE 1026 0.0077
702 SURGERY 452 0.0077
703 THERAPY PARTIAL RESPONDER 120 0.0077
704 HEART RATE INCREASED 762 0.0077
705 HYPOKALAEMIA 355 0.0077
706 DEVICE RELATED INFECTION 118 0.0077
707 ACUTE HEPATIC FAILURE 104 0.0076
708 PHOTOPHOBIA 143 0.0076
709 FLANK PAIN 71 0.0076
710 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 395 0.0076
711 PNEUMOTHORAX 120 0.0076
712 ANXIETY 2153 0.0076
713 ARTERIOSCLEROSIS 71 0.0075
714 COLITIS 285 0.0075
715 OESOPHAGITIS 82 0.0075
716 GENERALISED OEDEMA 92 0.0074
717 ACUTE RESPIRATORY DISTRESS SYNDROME 131 0.0074
718 POOR QUALITY SLEEP 159 0.0074
719 DISEASE RECURRENCE 351 0.0074
720 DYSPNOEA EXERTIONAL 277 0.0073
721 TEMPERATURE INTOLERANCE 75 0.0073
722 PRODUCT QUALITY ISSUE 977 0.0072
723 INFLUENZA LIKE ILLNESS 592 0.0072
724 TACHYCARDIA 639 0.0072
725 COAGULOPATHY 119 0.0071
726 NEUTROPHIL COUNT INCREASED 73 0.0071
727 EYE INFLAMMATION 68 0.0071
728 HAEMORRHOIDS 139 0.0071
729 APHONIA 99 0.0071
730 PULMONARY HYPERTENSION 145 0.0070
731 INJECTION SITE URTICARIA 170 0.0069
732 HEPATOMEGALY 68 0.0069
733 ACTIVITIES OF DAILY LIVING IMPAIRED 137 0.0069
734 OSTEONECROSIS OF JAW 171 0.0069
735 HEPATIC FAILURE 208 0.0069
736 JAUNDICE 185 0.0069
737 CHOLECYSTECTOMY 78 0.0068
738 TREATMENT NONCOMPLIANCE 373 0.0068
739 SINUS DISORDER 135 0.0068
740 EPISTAXIS 505 0.0067
741 ANGINA PECTORIS 193 0.0067
742 SKIN CANCER 145 0.0067
743 CORONARY ARTERY OCCLUSION 92 0.0067
744 SPLENOMEGALY 78 0.0067
745 BLOOD POTASSIUM INCREASED 108 0.0066
746 INJECTION SITE EXTRAVASATION 82 0.0066
747 PROTEINURIA 126 0.0066
748 PETECHIAE 69 0.0066
749 MYELODYSPLASTIC SYNDROME 95 0.0066
750 BONE MARROW FAILURE 133 0.0065
751 MACULAR DEGENERATION 78 0.0065
752 CARDIOMYOPATHY 96 0.0065
753 CHOLECYSTITIS 77 0.0065
754 OSTEONECROSIS 211 0.0064
755 CORONARY ARTERY DISEASE 194 0.0064
756 ANAEMIA 1215 0.0064
757 VERTIGO 388 0.0064
758 LYMPHOPENIA 90 0.0064
759 ANOREXIA 82 0.0064
760 SKIN HAEMORRHAGE 94 0.0063
761 MYOCARDIAL ISCHAEMIA 72 0.0063
762 PROCEDURAL PAIN 175 0.0063
763 GOUT 113 0.0063
764 SKIN FISSURES 123 0.0063
765 RENAL DISORDER 293 0.0063
766 ABASIA 155 0.0063
767 POST PROCEDURAL HAEMORRHAGE 73 0.0063
768 SWELLING FACE 408 0.0063
769 THROAT IRRITATION 280 0.0062
770 ACUTE RESPIRATORY FAILURE 120 0.0062
771 INJECTION SITE PAIN 1878 0.0061
772 RASH ERYTHEMATOUS 292 0.0061
773 THROMBOCYTOPENIA 683 0.0061
774 MITRAL VALVE INCOMPETENCE 69 0.0061
775 INTENTIONAL DOSE OMISSION 173 0.0061
776 MIDDLE INSOMNIA 113 0.0060
777 PERIPHERAL COLDNESS 83 0.0060
778 END STAGE RENAL DISEASE 110 0.0060
779 BRONCHOSPASM 86 0.0060
780 ASPIRATION 66 0.0060
781 CHILLS 706 0.0060
782 HIP FRACTURE 193 0.0060
783 FEELING ABNORMAL 1434 0.0060
784 FEELING JITTERY 114 0.0060
785 SYNCOPE 597 0.0060
786 RESTLESS LEGS SYNDROME 108 0.0059
787 EOSINOPHILIA 104 0.0059
788 PALPITATIONS 690 0.0059
789 BLOOD POTASSIUM DECREASED 177 0.0059
790 SNEEZING 132 0.0059
791 UNEVALUABLE EVENT 445 0.0059
792 MYOCARDIAL INFARCTION 1021 0.0058
793 ATRIAL FIBRILLATION 567 0.0058
794 CHOLESTASIS 111 0.0058
795 CARDIAC FAILURE 463 0.0058
796 MYALGIA 978 0.0057
797 COVID-19 1007 0.0057
798 CRYING 208 0.0057
799 ILLNESS 588 0.0057
800 ACUTE MYOCARDIAL INFARCTION 168 0.0057
801 CARDIOMEGALY 70 0.0057
802 NERVOUS SYSTEM DISORDER 177 0.0057
803 BLOOD TRIGLYCERIDES INCREASED 100 0.0057
804 FEELING COLD 157 0.0056
805 LEUKOCYTOSIS 102 0.0056
806 CARDIOVASCULAR DISORDER 143 0.0056
807 DYSPHONIA 328 0.0056
808 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1004 0.0056
809 BURNING SENSATION 390 0.0056
810 ECZEMA 291 0.0056
811 HYPERHIDROSIS 715 0.0055
812 SKIN DISCOLOURATION 255 0.0055
813 THROAT TIGHTNESS 150 0.0055
814 RESPIRATORY FAILURE 404 0.0055
815 HUNGER 77 0.0055
816 PULMONARY OEDEMA 247 0.0055
817 SWOLLEN TONGUE 171 0.0055
818 NEUTROPENIA 734 0.0054
819 BLINDNESS UNILATERAL 76 0.0054
820 INCORRECT PRODUCT ADMINISTRATION DURATION 116 0.0053
821 RASH MACULAR 187 0.0053
822 PERICARDIAL EFFUSION 122 0.0053
823 CARDIAC FAILURE CONGESTIVE 418 0.0052
824 TOOTH LOSS 106 0.0051
825 HAEMATEMESIS 128 0.0050
826 TRANSIENT ISCHAEMIC ATTACK 170 0.0050
827 DIABETES MELLITUS INADEQUATE CONTROL 89 0.0050
828 CHEST DISCOMFORT 514 0.0050
829 BLOOD UREA INCREASED 84 0.0050
830 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 129 0.0050
831 BREAST CANCER 467 0.0050
832 HOSPITALISATION 769 0.0050
833 TOXIC EPIDERMAL NECROLYSIS 76 0.0050
834 SARS-COV-2 TEST POSITIVE 66 0.0050
835 BLOOD BILIRUBIN INCREASED 135 0.0050
836 BONE LOSS 75 0.0050
837 HAEMATOCHEZIA 273 0.0049
838 ANGIOEDEMA 218 0.0049
839 ARRHYTHMIA 228 0.0048
840 RASH GENERALISED 124 0.0048
841 HAEMOPTYSIS 133 0.0048
842 COLD SWEAT 84 0.0048
843 HYPOAESTHESIA ORAL 71 0.0047
844 MULTIPLE ORGAN DYSFUNCTION SYNDROME 133 0.0047
845 PELVIC PAIN 85 0.0047
846 PRODUCT DOSE OMISSION IN ERROR 132 0.0047
847 LYMPHOCYTE COUNT DECREASED 82 0.0046
848 PULMONARY ARTERIAL HYPERTENSION 67 0.0046
849 RASH PAPULAR 103 0.0046
850 BONE PAIN 268 0.0046
851 LIP SWELLING 152 0.0046
852 INJECTION SITE HAEMORRHAGE 363 0.0045
853 UPPER GASTROINTESTINAL HAEMORRHAGE 76 0.0045
854 PLATELET COUNT DECREASED 480 0.0045
855 DYSPHAGIA 419 0.0044
856 POLLAKIURIA 184 0.0044
857 BLOOD PRESSURE DECREASED 293 0.0044
858 DRUG INTERACTION 697 0.0044
859 NERVOUSNESS 228 0.0044
860 TINNITUS 199 0.0043
861 MOOD SWINGS 138 0.0043
862 PRODUCT PRESCRIBING ERROR 103 0.0043
863 CARDIAC DISORDER 404 0.0043
864 LUNG NEOPLASM MALIGNANT 177 0.0043
865 HOT FLUSH 324 0.0043
866 DEPRESSED MOOD 227 0.0043
867 DYSURIA 158 0.0043
868 HYPOXIA 151 0.0043
869 TUBULOINTERSTITIAL NEPHRITIS 80 0.0043
870 AGEUSIA 106 0.0042
871 SPEECH DISORDER 222 0.0042
872 SKIN EXFOLIATION 356 0.0042
873 HYPOTENSION 845 0.0042
874 ABORTION SPONTANEOUS 168 0.0042
875 HAEMATOMA 108 0.0042
876 HEMIPARESIS 70 0.0041
877 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 226 0.0041
878 AGRANULOCYTOSIS 76 0.0041
879 COMA 193 0.0040
880 EYE PAIN 228 0.0040
881 GASTROINTESTINAL HAEMORRHAGE 337 0.0040
882 RENAL FAILURE ACUTE 170 0.0040
883 PALLOR 109 0.0040
884 HYPOACUSIS 169 0.0039
885 INTENTIONAL PRODUCT MISUSE 341 0.0039
886 BLINDNESS 158 0.0039
887 STEVENS-JOHNSON SYNDROME 86 0.0039
888 URINARY INCONTINENCE 114 0.0038
889 THIRST 68 0.0038
890 SOMNOLENCE 760 0.0038
891 ENCEPHALOPATHY 92 0.0037
892 DEHYDRATION 498 0.0037
893 HEAD INJURY 117 0.0037
894 EYE SWELLING 136 0.0037
895 FAECES DISCOLOURED 79 0.0036
896 BALANCE DISORDER 311 0.0036
897 DEVICE MALFUNCTION 252 0.0036
898 NEEDLE ISSUE 104 0.0036
899 SHOCK 82 0.0036
900 HAEMATURIA 122 0.0036
901 DIPLOPIA 92 0.0035
902 EYE PRURITUS 119 0.0035
903 INTESTINAL OBSTRUCTION 133 0.0035
904 LETHARGY 202 0.0035
905 ACUTE KIDNEY INJURY 530 0.0035
906 CEREBROVASCULAR ACCIDENT 585 0.0034
907 PERITONITIS 71 0.0034
908 ASCITES 100 0.0034
909 CHROMATURIA 76 0.0034
910 CEREBRAL INFARCTION 82 0.0034
911 PAIN OF SKIN 90 0.0033
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 96 0.0033
913 OCULAR HYPERAEMIA 155 0.0033
914 THERAPY INTERRUPTED 233 0.0033
915 FEAR 87 0.0032
916 INTERNATIONAL NORMALISED RATIO INCREASED 92 0.0032
917 PSYCHOTIC DISORDER 95 0.0032
918 MENTAL DISORDER 139 0.0032
919 PRODUCT DISPENSING ERROR 69 0.0032
920 TOXICITY TO VARIOUS AGENTS 529 0.0031
921 INJECTION SITE MASS 116 0.0031
922 MOOD ALTERED 85 0.0031
923 HYPOGLYCAEMIA 151 0.0031
924 EYE IRRITATION 178 0.0031
925 PRESYNCOPE 75 0.0031
926 RESPIRATORY DISTRESS 85 0.0031
927 PRODUCT DOSE OMISSION 200 0.0031
928 MELAENA 67 0.0030
929 PREMATURE BABY 91 0.0030
930 MYELOSUPPRESSION 108 0.0030
931 HAEMORRHAGE 312 0.0030
932 ACNE 226 0.0030
933 SUICIDAL IDEATION 272 0.0030
934 VISION BLURRED 406 0.0030
935 HYPERSOMNIA 84 0.0029
936 TREMOR 486 0.0029
937 FLATULENCE 164 0.0029
938 INCORRECT DOSE ADMINISTERED 655 0.0029
939 ABDOMINAL PAIN LOWER 72 0.0028
940 DISORIENTATION 110 0.0028
941 PRODUCT DOSE OMISSION ISSUE 805 0.0027
942 DRY SKIN 358 0.0027
943 DYSGEUSIA 199 0.0027
944 DISEASE PROGRESSION 315 0.0027
945 VISUAL ACUITY REDUCED 88 0.0026
946 APHASIA 80 0.0026
947 THERAPEUTIC RESPONSE UNEXPECTED 117 0.0026
948 DYSARTHRIA 98 0.0026
949 CHRONIC KIDNEY DISEASE 196 0.0026
950 FLUSHING 262 0.0026
951 HYPONATRAEMIA 145 0.0026
952 OVERDOSE 554 0.0026
953 DRUG DOSE OMISSION 422 0.0026
954 ACCIDENTAL OVERDOSE 93 0.0025
955 CONSTIPATION 543 0.0025
956 CARDIO-RESPIRATORY ARREST 104 0.0025
957 WRONG TECHNIQUE IN DRUG USAGE PROCESS 90 0.0025
958 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 172 0.0024
959 MULTIPLE SCLEROSIS 114 0.0024
960 DEVICE ISSUE 209 0.0023
961 LACRIMATION INCREASED 70 0.0023
962 NEUTROPHIL COUNT DECREASED 93 0.0023
963 NO ADVERSE EVENT 405 0.0022
964 SEIZURE 258 0.0022
965 HYPERGLYCAEMIA 81 0.0022
966 PANIC ATTACK 81 0.0022
967 RHABDOMYOLYSIS 92 0.0022
968 THERAPY CESSATION 113 0.0022
969 URINARY RETENTION 69 0.0021
970 BLOOD GLUCOSE INCREASED 387 0.0021
971 CARDIAC ARREST 156 0.0019
972 VAGINAL HAEMORRHAGE 82 0.0019
973 COGNITIVE DISORDER 87 0.0019
974 DEVICE BREAKAGE 75 0.0018
975 DYSKINESIA 74 0.0018
976 SKIN BURNING SENSATION 129 0.0018
977 DRUG DEPENDENCE 278 0.0017
978 DEPRESSED LEVEL OF CONSCIOUSNESS 67 0.0017
979 IRRITABILITY 98 0.0016
980 CONVULSION 93 0.0016
981 BLOOD GLUCOSE DECREASED 77 0.0016
982 DISTURBANCE IN ATTENTION 86 0.0016
983 DEATH 1348 0.0016
984 ACCIDENTAL EXPOSURE TO PRODUCT 158 0.0015
985 HALLUCINATION 114 0.0015
986 PRODUCT STORAGE ERROR 127 0.0014
987 AGITATION 104 0.0014
988 PROSTATE CANCER 107 0.0013
989 EMOTIONAL DISTRESS 154 0.0013
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 250 0.0012